3.2. Proteomic Comparison of AML Cells at Initial Diagnosis and Normal CD34+ Bone Marrow Cells: High Expression of Neutrophil Markers in the AML Cells and High Levels of Platelet/Coagulation Biomarkers in Normal Cells. This evidence concerns the gene CD34 and acute myeloid leukemia.